Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2022-03-01
2023-07-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study II on Remote Ischemic Conditioning for the Prevention of Stroke-Associated Pneumonia
NCT05982015
Ultra-early Chest CT for SAP Prediction
NCT07321275
Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke
NCT07247838
MUcociliary Clearance IN Stroke
NCT03884166
Stroke Registration of Young Adults in China
NCT03024164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
had a computed tomography scan of the chest within 24 hours after stroke onset
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji Xunming,MD,PhD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Suzhou Municipal Hospital
Suzhou, Anhui, China
People Hospital of Rongcheng
Baoding, Hebei, China
The Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
People Hospital of Ningjin
Xingtai, Hebei, China
Shihezi Municipal Hospital
Shihezi, Xinjiang, China
Xuanwu Hospital, Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhengfei Ma, MD
Role: primary
Mengge Zhang, MM
Role: primary
Fang Xue, MD
Role: primary
Fei Gu, MD
Role: primary
Naren Ya
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PICAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.